Sequential cisplatin-gemcitabine-docetaxel vs docetaxel-gemcitabine in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC):: Interim results of an ongoing phase II trial.

被引：0
|
作者：
Binder, D
Beinert, T
Schweisfurth, H
Grah, C
Temmesfeld-Wollbrock, B
Müller-Hagen, G
Schäper, C
Schürmann, D
Suttorp, N
机构：
[1] Med Klin Infektiolog, Berlin, Germany
[2] Klin Warternberg, Wartenberg, Germany
[3] Med Klin, Cottbus, Germany
[4] Med Klin Kardiol Pneumol, Berlin, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7113
引用
收藏
页码：644S / 644S
页数：1
相关论文
共 50 条
  • [21] Phase I study of docetaxel in combination with Gemcitabine as first line chemotherapy in patients with metastatic non-small cell lung cancer (NSCLC)
    Gatzemeier, U
    Bildat, S
    Harstrick, A
    Eberhardt, W
    Achterrath, W
    Krauss, C
    Wilke, HJ
    ANNALS OF ONCOLOGY, 1998, 9 : 93 - 93
  • [22] Phase II study of biweekly gemcitabine and docetaxel as first-line treatment for advanced disease in elderly non-small cell lung cancer (NSCLC) patients.
    Llorca, C.
    Esquerdo, G.
    Munoz, J., Sr.
    Sanchez-Hernandez, A.
    Gomez-Codina, J.
    Juan Vidal, O.
    Macia, S.
    Catot, S.
    Giner, V.
    Aparisi, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [23] A phase II/III randomized study in advanced non-small cell lung cancer (NSCLC) with first line combination versus sequential gemcitabine and docetaxel: Interim study results.
    Mueller, A
    Thatcher, N
    Kortsik, C
    Koschel, G
    Spengler, W
    Pilz, L
    Mezger, J
    Manegold, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 640S - 640S
  • [24] Phase II study of first-line sequential chemotherapy with gemcitabine-carboplatin followed by docetaxel in patients with advanced non-small cell lung cancer
    Chiappori, A
    Simon, G
    Williams, C
    Haura, E
    Rocha-Lima, C
    Wagner, H
    Bepler, G
    Antonia, S
    ONCOLOGY, 2005, 68 (4-6) : 382 - 390
  • [25] Phase I study of docetaxel in combination with gemcitabine as first line chemotherapy (CT) in patients with metastatic non-small cell lung cancer (NSCLC)
    Bildat, S
    Gatzemeier, U
    Reck, M
    Harstrick, A
    Eberhardt, W
    Achterrath, W
    Krauss, C
    Wilke, HJ
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S262 - S262
  • [26] A randomised multicentre phase II study with cisplatin/docetaxel vs oxaliplatin/docetaxel as first-line therapy in patients with advanced or metastatic non-small cell lung cancer
    A Atmaca
    S-E Al-Batran
    D Werner
    C Pauligk
    T Güner
    A Koepke
    H Bernhard
    T Wenzel
    A-G Banat
    P Brueck
    K Caca
    N Prasnikar
    F Kullmann
    H Günther Derigs
    M Koenigsmann
    G Dingeldein
    T Neuhaus
    E Jäger
    British Journal of Cancer, 2013, 108 : 265 - 270
  • [27] A randomised multicentre phase II study with cisplatin/docetaxel vs oxaliplatin/docetaxel as first-line therapy in patients with advanced or metastatic non-small cell lung cancer
    Atmaca, A.
    Al-Batran, S-E
    Werner, D.
    Pauligk, C.
    Guener, T.
    Koepke, A.
    Bernhard, H.
    Wenzel, T.
    Banat, A-G
    Brueck, P.
    Caca, K.
    Prasnikar, N.
    Kullmann, F.
    Derigs, H. Guenther
    Koenigsmann, M.
    Dingeldein, G.
    Neuhaus, T.
    Jaeger, E.
    BRITISH JOURNAL OF CANCER, 2013, 108 (02) : 265 - 270
  • [28] A phase II/III randomized study in advanced non-small-cell lung cancer (NSCLC) with first-line combination versus sequential gemcitabine and docetaxel:: second interim study results
    Müller, A
    Thatcher, N
    Kortsik, C
    Koschel, G
    Spengler, W
    Pitz, LR
    Mezger, J
    Manegold, C
    LUNG CANCER, 2004, 45 : S76 - S76
  • [29] Biweekly docetaxel and gemcitabine as first line chemotherapy in advanced non-small cell lung cancer (NSCLC)
    Gaspar, E.
    Firvida, J.
    Amenedo, M.
    Orts, D.
    Salgado, M.
    LLorca, C.
    Ramos, M.
    Perez, E.
    Cervera, J.
    Abal, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [30] A phase II trial of adding cetuximab to cisplatin and gemcitabine as first-line therapy in advanced non-small cell lung cancer (NSCLC)
    Barata, F.
    Parente, B.
    Teixeira, E.
    Costa, A.
    Fernandes, A.
    Pimentel, F. L.
    Carvalho, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345